Home

Nonaktif aktivitas taktik cea 125 roche marker premium Memperluas Ingin

Reference ranges for HE4 and CA125 in a large Asian population by automated  assays and diagnostic performances for ovarian cancer - Park - 2012 -  International Journal of Cancer - Wiley Online Library
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library

Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor  burden in patients with advanced high-grade serous ovarian cancer | PLOS ONE
Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer | PLOS ONE

JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older  Women: A Population-Based Analysis
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis

CA125 as a predictor of endometrial cancer lymphovascular space invasion  and lymph node metastasis for risk stratification in the preoperative  setting | Scientific Reports
CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting | Scientific Reports

Distribution of tumor marker levels in various patient groups. Box... |  Download Scientific Diagram
Distribution of tumor marker levels in various patient groups. Box... | Download Scientific Diagram

CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in  discrimination of benign and malign epithelial ovarian tumor
CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor

Clinical analysis of four serum tumor markers in 458 patients with ova |  CMAR
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR

Frontiers | Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate  Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1  and VEGF Inhibition
Frontiers | Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition

JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older  Women: A Population-Based Analysis
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis

Performance of preoperative plasma tumor markers HE4 and CA125 in  predicting ovarian cancer mortality in women with epithelial ovarian cancer  | PLOS ONE
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE

Reference ranges for HE4 and CA125 in a large Asian population by automated  assays and diagnostic performances for ovarian cancer - Park - 2012 -  International Journal of Cancer - Wiley Online Library
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library

Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome  in First Relapse of Platinum-sensitive Serous Ovarian Cancer | Anticancer  Research
Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome in First Relapse of Platinum-sensitive Serous Ovarian Cancer | Anticancer Research

Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC  for Lung Cancer Screening by Combining ROC Curve and Logistic Regression  Analyses: Is It Feasible?
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?

Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study  Subanalysis - ScienceDirect
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis - ScienceDirect

Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular  subtype: a cohort study | SpringerLink
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink

Rising serum CA-125 levels within the normal range is strongly associated  recurrence risk and survival of ovarian cancer | Journal of Ovarian  Research | Full Text
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text

Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other  Pulmonary Infections
Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other Pulmonary Infections

Nadir CA-125 has prognostic value for recurrence, but not for survival in  patients with ovarian cancer | Scientific Reports
Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports

Performance of preoperative plasma tumor markers HE4 and CA125 in  predicting ovarian cancer mortality in women with epithelial ovarian cancer  | PLOS ONE
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE

Elecsys® CA 125 II
Elecsys® CA 125 II

Downregulation of cell surface CA125/MUC16 induces  epithelial-to-mesenchymal transition and restores EGFR signalling in  NIH:OVCAR3 ovarian carcinoma cells | British Journal of Cancer
Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells | British Journal of Cancer

Prognostic and predictive value of combined HE-4 and CA-125 biomarkers  during chemotherapy in patients with epithelial ovarian cancer - Enrico  Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo  Zola,
Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,

JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older  Women: A Population-Based Analysis
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis

Utility of serum CA-125 monitoring in patients with ovarian cancer  undergoing immune checkpoint inhibitor therapy - ScienceDirect
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy - ScienceDirect

CA 125: Ovarian Tumor Marker Blood Test Results
CA 125: Ovarian Tumor Marker Blood Test Results

Rising serum CA-125 levels within the normal range is strongly associated  recurrence risk and survival of ovarian cancer | Journal of Ovarian  Research | Full Text
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text

CA 125 II ELECSYS/e 411 ROCHE 100T - Τολιόπουλος Διαγνωστικά
CA 125 II ELECSYS/e 411 ROCHE 100T - Τολιόπουλος Διαγνωστικά